The application of gene co-expression network reconstruction based on CNVs and gene expression microarray data in breast cancer

Copy number variations (CNVs) are one type of the human genetic variations and are pervasive in the human genome. It has been confirmed that they can play a causal role in complex diseases. Previous studies of CNVs focused more on identifying the disease-specific CNV regions or candidate genes on these CNV regions, but less on the synergistic actions between genes on CNV regions and other genes. Our research combined the CNVs with related gene co-expression to reconstruct gene co-expression network by using single nucleotide polymorphism microarray datasets and gene microarray datasets of breast cancer, and then extracted the modules which connected densely inside and analyzed the functions of modules. Interestingly, all of these modules’ functions were related to breast cancer according to our enrichment analysis, and most of the genes in these modules have been reported to be involved in breast cancer. Our findings suggested that integrating CNVs and gene co-expressed relations was an available way to analyze the roles of CNV genes and their synergistic genes in breast cancer, and provided a novel insight into the pathological mechanism of breast cancer.

[1]  Nicholas J Wareham,et al.  IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. , 2006, Human molecular genetics.

[2]  Hae-June Lee,et al.  Differential Gene Signatures in Rat Mammary Tumors Induced by DMBA and Those Induced by Fractionated γ Radiation , 2008, Radiation research.

[3]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[4]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[5]  Wen-qin Song,et al.  CD1d gene is a target for a novel amplicon at 1q22–23.1 in human hepatocellular carcinoma , 2009, Molecular Biology Reports.

[6]  A. Janecka,et al.  The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line , 2011, Molecular Biology Reports.

[7]  C. Iacobuzio-Donahue,et al.  The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. , 2002, Cancer research.

[8]  S. Poppema,et al.  CD69+ and HLA‐DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: Correlations with survival following active specific immunotherapy , 1995, International journal of cancer.

[9]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[10]  Yeul-Hong Kim,et al.  DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC) , 2009, Molecular Biology Reports.

[11]  R. Redon,et al.  Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.

[12]  Wei Zhou,et al.  In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models , 2009, Clinical Cancer Research.

[13]  T. Sørlie,et al.  Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome , 2008, The Journal of pathology.

[14]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[15]  Emmanuel Barillot,et al.  Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells , 2008, Breast Cancer Research.

[16]  Louise V Wain,et al.  Genomic copy number variation, human health, and disease , 2009, The Lancet.

[17]  James D Iglehart,et al.  Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. , 2007, Cancer cell.

[18]  Mitsutaka Kadota,et al.  Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA. , 2009, Cancer research.

[19]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[20]  D. Kerr,et al.  Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk , 2008, Nature Genetics.

[21]  S. Gelling,et al.  Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer , 2005, The Journal of pathology.

[22]  H. Jacobs,et al.  Overexpression of MTERFD1 or MTERFD3 impairs the completion of mitochondrial DNA replication , 2011, Molecular Biology Reports.

[23]  F. Kittrell,et al.  From Mice to Humans , 2004, Cancer Research.

[24]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[25]  C. Der,et al.  Aberrant function of the Ras signal transduction pathway in human breast cancer , 1995, Breast Cancer Research and Treatment.

[26]  河村 大輔,et al.  Genome-wide detection of human copy number variations using high density DNA oligonucleotide arrays , 2007 .

[27]  Renée X. de Menezes,et al.  Integrated analysis of DNA copy number and gene expression microarray data using gene sets , 2009, BMC Bioinformatics.

[28]  E. Petty,et al.  Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells , 2000, Genes, chromosomes & cancer.

[29]  S. Horvath,et al.  Statistical Applications in Genetics and Molecular Biology , 2011 .

[30]  Carsten Denkert,et al.  Genome-wide Gene Expression Profiling of Formalin-fixed Paraffin-Embedded Breast Cancer Core Biopsies Using Microarrays , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  Jun Yao,et al.  Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression , 2008, Clinical Cancer Research.

[32]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[33]  M. Stratton,et al.  The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website , 2004, British Journal of Cancer.

[34]  Jeffrey T. Chang,et al.  Anchorage-independent cell growth signature identifies tumors with metastatic potential , 2009, Oncogene.

[35]  I. Degirmenci,et al.  Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines , 2011, Molecular Biology Reports.

[36]  Yusuke Nakamura,et al.  PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer. , 2006, Cancer research.

[37]  R. Salunga,et al.  Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[39]  K. Sneppen,et al.  Specificity and Stability in Topology of Protein Networks , 2002, Science.

[40]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[41]  D. Mukhopadhyay,et al.  CUGBP2 Plays a Critical Role in Apoptosis of Breast Cancer Cells in Response to Genotoxic Injury , 2003, Annals of the New York Academy of Sciences.

[42]  J. Squire,et al.  Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma , 2005, International journal of cancer.

[43]  R. Tsien,et al.  Specificity and Stability in Topology of Protein Networks , 2022 .

[44]  Wei Zhang,et al.  Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients , 2007, Breast Cancer Research and Treatment.

[45]  I. Gout,et al.  Identification of a novel binding partners for tumor suppressor PTEN by a yeast two-hybrid approach. , 2004, Eksperimental'naia onkologiia.

[46]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[47]  B. Weaver,et al.  Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. , 2005, Cancer cell.

[48]  Luc Girard,et al.  An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. , 2004, Cancer research.

[49]  M. J. van de Vijver,et al.  Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.

[50]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[51]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[52]  J. Son,et al.  Copy number variations of chromosome 17p13.1 might be linked to high risk of lung cancer in heavy smokers , 2011, Molecular Biology Reports.

[53]  Howard Y. Chang,et al.  Genetic regulators of large-scale transcriptional signatures in cancer , 2006, Nature Genetics.

[54]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[55]  R. Strieter.  Chemokines: Not just leukocyte chemoattractants in the promotion of cancer , 2001, Nature Immunology.

[56]  Andrew H. Beck,et al.  The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma , 2009, Clinical Cancer Research.

[57]  John H. White,et al.  Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells , 2007, Nucleic acids research.

[58]  L. Hartwell,et al.  Cell cycle control and cancer. , 1994, Science.

[59]  Andrew M Fry,et al.  The Centrosomal Kinase Nek2 Displays Elevated Levels of Protein Expression in Human Breast Cancer , 2004, Cancer Research.

[60]  D. Yee,et al.  A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. , 2003, Cancer research.

[61]  K. Hemminki,et al.  Polymorphisms in the KDR and POSTN Genes: Association with Breast Cancer Susceptibility and Prognosis , 2006, Breast Cancer Research and Treatment.

[62]  N. Schork,et al.  Identification of rare cancer driver mutations by network reconstruction. , 2009, Genome research.

[63]  Shridar Ganesan,et al.  X chromosomal abnormalities in basal-like human breast cancer. , 2006, Cancer cell.

[64]  P. Jagodziński,et al.  CCL2 −2518 A/G single nucleotide polymorphism as a risk factor for breast cancer , 2011, Molecular Biology Reports.

[65]  Zhiyuan Hu,et al.  Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  Zsolt Tulassay,et al.  Diagnostic mRNA Expression Patterns of Inflamed, Benign, and Malignant Colorectal Biopsy Specimen and their Correlation with Peripheral Blood Results , 2008, Cancer Epidemiology Biomarkers & Prevention.

[67]  A. Chambers,et al.  Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment. , 2009, International journal of oncology.

[68]  M. Grimm,et al.  Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. , 2006, Cancer research.

[69]  L. Carey,et al.  CYP2D6 and tamoxifen: DNA matters in breast cancer , 2009, Nature Reviews Cancer.

[70]  T. Golub,et al.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.

[71]  Hongjuan Zhao,et al.  TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer , 2007, Breast Cancer Research.

[72]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[73]  M. Pike,et al.  Increased cell division as a cause of human cancer. , 1990, Cancer research.

[74]  A. Harris,et al.  Tumor-Associated Macrophages in Breast Cancer , 2002, Journal of Mammary Gland Biology and Neoplasia.

[75]  J. Lafuente,et al.  DNA Copy Number Variation and Gene Expression Analyses Reveal the Implication of Specific Oncogenes and Genes in GBM , 2009, Cancer Investigation.

[76]  Yusuke Nakamura,et al.  Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. , 2009, Cancer research.